AzTrials
AzTrials

Laryngeal Mask AirwayNCT04520555

Flexible Laryngeal Mask Airway Versus Tracheal Intubation in Nasal Bone Fracture

A study testing Laryngeal mask airway and Endotracheal tube in people with Laryngeal Mask Airway, run by Ajou University School of Medicine at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In surgery under general anesthesia due to nasal bone fracture, laryngeal mask airway or tracheal intubation has been used. However, it has not been investigated that the difference of recovery profiles according to use of laryngeal mask airway or tracheal intubation in nasal bone fracture surgery. Read more about this study

Who is it for?
Ages 19 to 70 years
Conditions the study is for
Laryngeal Mask Airway
What is being tested?
Laryngeal mask airway and Endotracheal tube
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteSouth Korea
Study dates
13 Jul 2020to 27 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with American Society of Anesthesiologists classification 1 or 2 who receive general anesthesia due to nasal bone fracture

Who cannot join

  • Patients with high risk of aspiration, patients who anticipated difficult airway

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Ajou University Hospital

    Suwon, Gyeongki-do, 443-721

Other trials in South Korea

About this study

Official title: Comparison of Recovery Profiles Between Flexible Laryngeal Mask Airway and Tracheal Intubation in Nasal Bone Fracture

In surgery under general anesthesia due to nasal bone fracture, laryngeal mask airway or tracheal intubation has been used. However, it has not been investigated that the difference of recovery profiles according to use of laryngeal mask airway or tracheal intubation in nasal bone fracture surgery. The aim of study is to evaluate the efficacy of the laryngeal mask airway regarding recovery profiles and airway complications, compared to tracheal intubation.

Being tested
Laryngeal mask airway, Endotracheal tube
Keywords
Laryngeal mask airway, Intubation, nasal bone fracture, recovery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laryngeal mask airwayDevice

    Also called LMA Flexible,Teleflex Co., Westmeath, Ireland

    LMA Flexible is a supraglottic airway device, which can be moved out of the surgical field without displacement of the cuff, or loss of seal for the anesthetist

  • Endotracheal tubeDevice

    Also called Portex, Smiths Medical International Ltd., South East England, United Kingdom

    Endotracheal tube is a plain tube, which is most commonly used in general anesthesia.

Study groups in NCT04520555
Study groupRoleWhat they receive
Laryngeal mask airway groupExperimentalFlexible laryngeal mask airway is inserted for general anesthesia
Receives: Device: Laryngeal mask airway
intubation groupActive comparatorEndotracheal intubation was performed for general anesthesia
Receives: Device: Endotracheal tube

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cough during extubation

    Grade of cough during periextubation periods (0=no cough, 1=single cough, 2=more than one episode of non-sustained cough, 3=sustained and repetitive cough with head lift)

    Measured: From end of surgery to extubation

Secondary outcomes (11)
  1. Adequate tidal volume during mechanical ventilation

    Tidal volume (ml)

    Measured: From insertion of airway device to extubation

  2. Adequate ventilation during mechanical ventilation

    end-tidal carbon dioxide

    Measured: From insertion of airway device to extubation

  3. Airway pressure during mechanical ventilation

    peak and mean airway pressure

    Measured: From insertion of airway device to extubation

  4. Changes of heart rate

    Heart rate

    Measured: Before anethetic induction, 1 minute after intubation, the end of surgery, 1 minute after extubation.

  5. Changes of blood pressure

    mean blood pressure

    Measured: Before anethetic induction, 1 minute after intubation, the end of surgery, 1 minute after extubation.

  6. Changes of saturation

    peripheral saturation

    Measured: Before anethetic induction, 1 minute after intubation, the end of surgery, 1 minute after extubation.

  7. Number of Participants with blood contamination at vocal cord and distal trachea

    Blood contamination was examined using fibrobronchoscope.

    Measured: Between the end of surgery and extubation

  8. Device blood contamination

    0=no contamination, 1=external contamination of the tube, 2=some soilage of the inner surface of the tube, 3=frank coating of the inner surface of the tube

    Measured: At airway device removal

  9. Number of Participants with airway complications after extubation

    laryngospasm, hypoventilation (respiratory rate <8/minutes), desaturation (peripheral pulse oximetry saturation <95%)

    Measured: From extubation to 5 minutes after extubation

  10. Time to eye opening and time to extubation

    Time in seconds from anesthetic discontinuation to eye opening at verbal commend and time in seconds from anesthetic discontinuation to extubation

    Measured: From anesthetic discontinuation to eye opening and extubation

  11. Number of Participants with postoperative airway complications

    Sore throat, hoarseness, dysphagia, and nausea and vomiting

    Measured: 30 minutes after surgery and postoperative 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2020
  2. Study start13 Jul 2020
  3. Primary completion26 Jan 2022
  4. Study completion27 Jan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04520555
Sponsor's protocol ID
AJIRB-MED-OBS-20-081
Status last verified
Jul 2022
First submitted
12 Aug 2020
Last updated
20 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Laryngeal mask airway and Endotracheal tube in people with Laryngeal Mask Airway, run by Ajou University School of Medicine at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cough during extubation (time frame: From end of surgery to extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in